Manuscript Submission

The manuscript is only accepted if neither the article nor any essential part of this has been published previously and is submitted exclusively to the journal FARMACIA.

Manuscripts for FARMACIA should be submitted online at https://farmaciajournal.com/login. The submitting author, who is generally the corresponding author, is responsible for the manuscript during the submission and peer-review process. The submitting author must ensure that all eligible co-authors have been included in the author list and that they have all read and approved the submitted version of the manuscript.

All manuscript submissions to FARMACIA must be accompanied by a cover letter, submitted as a separate document. The cover letter is an essential component of the submission and will be considered during the initial editorial assessment.

Content of the Cover Letter

The cover letter should be concise, yet sufficiently informative, and must include the following elements:

1. Brief description of the manuscript
   • A short summary outlining the scientific rationale, objectives, methodology, and main findings of the study.
   • A clear statement highlighting the originality, novelty, and relevance of the work to the scope of FARMACIA and the pharmaceutical sciences.
2. Statement of originality and exclusivity
   • Confirmation that the submitted manuscript reports the results of an original study presenting novel work.
   • A declaration that the manuscript has not been previously published, in whole or in part, and is not under consideration for publication elsewhere.
3. Author approval and responsibility
   • Confirmation that all authors have read and approved the final version of the manuscript.
   • A statement that all authors agree with the submission to FARMACIA and take responsibility for the content of the work.
4. Ethical compliance
   Where applicable, the cover letter must explicitly state that:
   • The study was conducted in accordance with recognized ethical standards.
   • Clinical research involving human participants complies with the principles of the Declaration of Helsinki.
   • Experimental research involving animals complies with Directive 2010/63/EU on the protection of animals used for scientific purposes.
   • Ethical approval was obtained from the appropriate institutional or national ethics committee, and written informed consent was obtained from participants when required.
5. Conflicts of interest disclosure
   • A clear disclosure of any financial or non-financial competing interests that could be perceived as influencing the research, or an explicit statement declaring that no competing interests exist.
6. Authorship declaration and signed documentation
   • The cover letter and the accompanying disclosure form must be signed by all authors.
   • These documents must confirm that the work is original, that all authors consent to submission, and that the manuscript is not under consideration by another journal.
7. Corresponding author information
   The cover letter must clearly indicate the designated corresponding author and provide the following contact details:
   • Full name
   • Institutional affiliation and postal address
   • Telephone number
   • E-mail address

Editorial Considerations

Incomplete cover letters or missing declarations may result in delays in the editorial process or return of the manuscript prior to peer review. Submission of a cover letter implies acceptance of the journal’s editorial policies and ethical standards.